Cigna Group (NYSE:CI) Now Covered by Analysts at Evercore

Key Points

• Evercore initiated coverage of Cigna Group with an “in-line” rating and a $290 price target, implying approximately 6.05% upside from the reported share price.
• Cigna has a consensus “Moderate Buy” rating from analysts, with 15 Buy ratings and eight Holds; the average price target is $337.10.
• The company recently reported quarterly EPS of $7.78, beating estimates of $7.60, while revenue rose 6.7% year over year to $70.04 billion.

Investment analysts at Evercore began coverage on shares of Cigna Group (NYSE:CI - Get Free Report) in a research report issued to clients and investors on Wednesday, MarketBeat.com reports. The firm set an "in-line" rating and a $290.00 price target on the health services provider's stock. Evercore's price target would indicate a potential upside of 6.05% from the company's current price.

A number of other equities research analysts have also weighed in on CI. Wolfe Research reiterated an "outperform" rating and set a $315.00 price objective on shares of Cigna Group in a report on Tuesday, June 16th. Mizuho raised their price target on shares of Cigna Group from $330.00 to $340.00 and gave the company an "outperform" rating in a report on Monday, June 8th. Robert W. Baird set a $362.00 target price on Cigna Group in a research report on Friday, July 31st. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Cigna Group in a report on Thursday, August 27th. Finally, UBS Group raised their price objective on Cigna Group from $375.00 to $400.00 and gave the stock a "buy" rating in a research note on Friday, May 22nd. Fifteen analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $337.10.

Cigna Group Stock Performance

Shares of CI stock traded down $2.37 during trading hours on Wednesday, reaching $273.46. 62,404 shares of the company traded hands, compared to its average volume of 1,675,409. The firm has a 50-day moving average price of $283.56 and a 200 day moving average price of $280.84. The company has a market cap of $72.26 billion, a P/E ratio of 11.35, a P/E/G ratio of 0.97 and a beta of 0.31. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. Cigna Group has a 12-month low of $239.51 and a 12-month high of $315.47.

Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $7.60 by $0.18. The firm had revenue of $70.04 billion during the quarter, compared to analysts' expectations of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company's revenue for the quarter was up 6.7% compared to the same quarter last year. During the same period in the prior year, the company posted $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, sell-side analysts predict that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Insider Activity at Cigna Group

In other Cigna Group news, insider Everett Neville sold 617 shares of the business's stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the transaction, the insider directly owned 5,053 shares of the company's stock, valued at approximately $1,435,304.65. The trade was a 10.88% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie Kates sold 899 shares of the firm's stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. The trade was a 27.52% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 23,629 shares of company stock worth $6,561,809. 0.60% of the stock is owned by corporate insiders.

Institutional Trading of Cigna Group

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Wilkerson Advisory Group LLC acquired a new position in Cigna Group in the 4th quarter worth about $25,000. Osbon Capital Management LLC acquired a new stake in Cigna Group in the second quarter valued at approximately $26,000. Cedar Mountain Advisors LLC increased its position in shares of Cigna Group by 161.9% in the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider's stock valued at $29,000 after buying an additional 68 shares in the last quarter. Johnson Financial Group Inc. acquired a new position in shares of Cigna Group during the 2nd quarter worth approximately $29,000. Finally, Fiduciary Financial Advisors purchased a new position in shares of Cigna Group during the 2nd quarter valued at approximately $29,000. Institutional investors and hedge funds own 86.99% of the company's stock.

About Cigna Group

The Cigna Group NYSE: CI is a global health services company that helps individuals, employers, health plans and government organizations access health care and related services. The company operates primarily through two businesses: Cigna Healthcare, which provides medical, behavioral health, dental and other health benefit products and services, and Evernorth Health Services, which offers pharmacy, care delivery and health benefits solutions.

Evernorth includes Express Scripts, a pharmacy benefit services provider that manages prescription drug benefits and operates home delivery and specialty pharmacy services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.